India to Philippines: Syringe Export Trade Route
India has recorded 97 verified shipments of Syringe exported to Philippines, representing a combined trade value of $11.2M USD. This corridor is served by 19 active Indian exporters, with an average shipment value of $115.8K USD. The leading Indian exporter is INDIAN IMMUNOLOGICALS LIMITED, which accounts for 74% of total export value with 24 shipments worth $8.3M USD. On the buying side, 2 WORLD TRADERS INC is the largest importer in Philippines with $8.8M USD in purchases. The top 3 suppliers — INDIAN IMMUNOLOGICALS LIMITED, BRAWN LABORATORIES LIMITED, INDIAN IMMUNOLOGICALS LTD — together control 89% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Syringe corridor is one of India's established pharmaceutical export routes, with 97 shipments documented worth a combined $11.2M USD. The route is dominated by INDIAN IMMUNOLOGICALS LIMITED, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's syringe manufacturing sector.
Across 19 active suppliers, the average shipment value stands at $115.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with syringe's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 26.2%, placing it at rank #16 among India's top syringe export destinations globally.
On the import side, key buyers of Indian syringe in Philippines include 2 WORLD TRADERS INC, AMBICA INTERNATIONAL CORPORATION, 2MG 2MG INC and 20 others. 2 WORLD TRADERS INC is the single largest importer with 24 shipments valued at $8.8M USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ4
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#16
- Annual growth+26.2%
- Demand growth+22.1%
- Regulatory ease88/100
Top 10 Indian Syringe Exporters to Philippines
Showing top 10 of 19 Indian suppliers exporting Syringe to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INDIAN IMMUNOLOGICALS LIMITED Avg $347.3K per shipment | 24 | $8.3M | 74.2% |
| 2 | BRAWN LABORATORIES LIMITED Avg $27.5K per shipment | 31 | $853.7K | 7.6% |
| 3 | INDIAN IMMUNOLOGICALS LTD Avg $796.3K per shipment | 1 | $796.3K | 7.1% |
| 4 | VENUS REMEDIES LIMITED Avg $197.6K per shipment | 2 | $395.1K | 3.5% |
| 5 | GLAND PHARMA LIMITED Avg $44.8K per shipment | 8 | $358.1K | 3.2% |
| 6 | ZYDUS LIFESCIENCES LIMITED Avg $58.4K per shipment | 2 | $116.7K | 1.0% |
| 7 | ZYDUS LIFESCIENCES LIMITED Avg $54.1K per shipment | 2 | $108.1K | 1.0% |
| 8 | BIOVENCER HEALTHCARE PRIVATE LIMITED Avg $7.2K per shipment | 12 | $86.5K | 0.8% |
| 9 | CADILA HEALTHCARE LIMITED Avg $74.9K per shipment | 1 | $74.9K | 0.7% |
| 10 | PROFILE AXIS PRIVATE LIMITED Avg $8.1K per shipment | 3 | $24.4K | 0.2% |
This table shows the top 10 of 19 Indian companies exporting syringe to Philippines, ranked by total trade value. The listed exporters are: INDIAN IMMUNOLOGICALS LIMITED, BRAWN LABORATORIES LIMITED, INDIAN IMMUNOLOGICALS LTD, VENUS REMEDIES LIMITED, GLAND PHARMA LIMITED, ZYDUS LIFESCIENCES LIMITED , ZYDUS LIFESCIENCES LIMITED, BIOVENCER HEALTHCARE PRIVATE LIMITED, CADILA HEALTHCARE LIMITED, PROFILE AXIS PRIVATE LIMITED. INDIAN IMMUNOLOGICALS LIMITED is the dominant supplier with 24 shipments worth $8.3M USD, giving it a 74% market share. The top 3 suppliers together account for 89% of the total trade value on this route.
Showing top 10 of 19 total Indian exporters on the India to Philippines Syringe export route.
Top 10 Syringe Importers in Philippines
Showing top 10 of 23 known buyers in Philippines receiving Syringe shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian syringe in Philippines include 2 WORLD TRADERS INC, AMBICA INTERNATIONAL CORPORATION, 2MG 2MG INC, ENDURE MEDICAL INC., 2 WORLD TRADERS, INC,, among 23 total buyers. The largest importer is 2 WORLD TRADERS INC, accounting for $8.8M USD across 24 shipments — representing 78% of all syringe imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | 2 WORLD TRADERS INC | 24 | $8.8M | 78.3% |
| 2 | AMBICA INTERNATIONAL CORPORATION | 26 | $714.4K | 6.4% |
| 3 | 2MG 2MG INC | 2 | $395.1K | 3.5% |
| 4 | ENDURE MEDICAL INC. | 8 | $358.1K | 3.2% |
| 5 | 2 WORLD TRADERS, INC, | 1 | $332.0K | 3.0% |
| 6 | NA | 5 | $139.4K | 1.2% |
| 7 | ZYDUS HEALTHCARE PHILIPPINES INC | 2 | $128.3K | 1.1% |
| 8 | ZYDUS HEALTHCARE PHILIPPINES INC. | 2 | $116.7K | 1.0% |
| 9 | TO THE ORDER OF | 4 | $70.0K | 0.6% |
| 10 | ZYDUS HEALTHCARE PHILIPPINES INC. | 1 | $54.7K | 0.5% |
Showing top 10 of 23 Syringe importers in Philippines on this route.
Top 10 Syringe Formulations Imported by Philippines
Showing top 10 of 74 product formulations shipped on the India to Philippines Syringe route, ranked by trade value
Philippines imports a wide range of syringe formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ABHAYRAB 0.5ML BP(HUMAN RABIES VACCINE WITH DISPOSABLE SYRINGE AND DILUENT) — accounts for $3.1M USD across 8 shipments. There are 74 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ABHAYRAB 0.5ML BP(HUMAN RABIES VACCINE WITH DISPOSABLE SYRINGE AND DILUENT) | 8 | $3.1M | 28.0% |
| 2 | ABHAYRAB 0.5ML B.P(HUMAN RABIES VACCINEWITH DISPOSABLE SYRINGE AND DILUENTS) | 2 | $933.2K | 8.3% |
| 3 | ABHAYRAB 0.5ML B.P HUMAN RABIES VACCINEWITH DISPOSABLE SYRINGE AND DILUENTSBATCH NO:23URAB056,23URAB057,23URAB058 | 1 | $796.3K | 7.1% |
| 4 | ABHAYRAB 0 5ML BP HUMAN RABIES VACCINE WITH DISPOSABLE SYRINGE AND DILUENT | 2 | $746.2K | 6.6% |
| 5 | ABHAYRAB 0.5ML B.P (HUMAN RABIES VACCINEWITH DISPOSAL SYRINGE AND DILUENTS) BATCH NO:23URAB064 & B065 (TTL- 95333 VIALS | 1 | $525.3K | 4.7% |
| 6 | ABHAYRAB 0.5ML B.P (HUMAN RABIES VACCINEWITH DISPOSAL SYRINGE AND DILUENTS) BATCH NO:23URAB059, B063 & B064 (TTL- 95333 | 1 | $522.5K | 4.7% |
| 7 | ABHAYRAB 0.5ML B.P HUMAN RABIES VACCINEWITH DISPOSAL SYRINGE AND DILUENTS BATCH NO:23URAB059 B063 & B064 TTL- 95333 | 1 | $522.4K | 4.7% |
| 8 | ABHAYRAB 0.5ML B.PHUMAN RABIES VACCINEWITH DISPOSABLE SYRINGE AND DILUENT | 2 | $516.1K | 4.6% |
| 9 | ABHAYRAB 0.5ML B.P (HUMAN RABIES VACCINEWITH DISPOSABLE SYRINGE AND DILUENT) BATCH NO:24URAB030 | 1 | $352.7K | 3.1% |
| 10 | ABHAYRAB 0.5ML BP(HUMAN RABIES VACCINE WITH DISPOSABLE SYRINGE AND DILUENTS) | 1 | $351.9K | 3.1% |
Showing top 10 of 74 Syringe formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 31 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's syringe exports to Philippines are driven primarily by a handful of large-scale manufacturers. INDIAN IMMUNOLOGICALS LIMITED with 24 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INDIAN IMMUNOLOGICALS LIMITED, BRAWN LABORATORIES LIMITED, INDIAN IMMUNOLOGICALS LTD — together account for 89% of total trade value on this route. The average shipment value of $115.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as abhayrab 0.5ml b.p(human rabies vaccinewith disposable syringe and diluents) and abhayrab 0.5ml b.p human rabies vaccinewith disposable syringe and diluentsbatch no:23urab056,23urab057,23urab058, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, 2 WORLD TRADERS INC is the largest importer with 24 shipments worth $8.8M USD — representing 78% of all syringe imports from India on this route. A total of 23 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $11.2M
- Avg. Shipment
- $115.8K
- Suppliers
- 19
- Buyers
- 23
- Transit (Sea)
- ~25 days
- Annual Growth
- +26.2%
Other Syringe Routes
Unlock the Full India to Philippines Syringe Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 97 shipments on this route.
Frequently Asked Questions — India to Philippines Syringe Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Syringe to Philippines?
The leading Indian exporters of Syringe to Philippines are INDIAN IMMUNOLOGICALS LIMITED, BRAWN LABORATORIES LIMITED, INDIAN IMMUNOLOGICALS LTD. INDIAN IMMUNOLOGICALS LIMITED holds the largest market share at approximately 74% of total trade value on this route.
Q What is the total value of Syringe exports from India to Philippines?
India exports Syringe to Philippines worth approximately $11.2M USD across 97 recorded shipments. The average value per shipment is $115.8K USD.
Q Which ports does India use to ship Syringe to Philippines?
The most active port of origin is DELHI AIR with 31 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Philippines for Syringe?
The average transit time for Syringe shipments from India to Philippines is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Philippines Syringe trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.2% with demand growth tracking at 22.1%. The route is ranked #16 among India's top Syringe export destinations globally.
Q How many suppliers are active on the India to Philippines Syringe route?
There are currently 19 active Indian suppliers exporting Syringe to Philippines. The market is moderately concentrated with INDIAN IMMUNOLOGICALS LIMITED accounting for 74% of total shipment value.
Q Who are the main importers of Syringe from India in Philippines?
The leading importers of Indian Syringe in Philippines include 2 WORLD TRADERS INC, AMBICA INTERNATIONAL CORPORATION, 2MG 2MG INC, ENDURE MEDICAL INC., 2 WORLD TRADERS, INC,. 2 WORLD TRADERS INC is the largest buyer with 24 shipments worth $8.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Syringe.
- 2.Supplier/Buyer Matching: 19 Indian exporters and 23 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 97 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
97 Verified Shipments
19 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists